Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations against TransMedics Group, Inc. (™DX) By Investing.com
    News

    Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations against TransMedics Group, Inc. (™DX) By Investing.com

    userBy userJanuary 11, 2025No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    NEW YORK – January 11, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group (NASDAQ:), Inc. (TransMedics or the Company) (NASDAQ: ™DX).

    CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

    If you are a TransMedics investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.

    On January 10, 2025, Scorpion Capital published a short report entitled, Walk Like An Egyptian: A Mafia-Style Extortion, Racketeering, And Organ Trafficking Scheme Masquerading And A Medical (TASE:) Device Company Fueled By Kickbacks, Billing Fraud, Unreported Device Failures, And Off-Label Misuse On A Vast Scale; Precipitating A Customer Exodus And Rapidly Unfolding Death Spiral. Target (NYSE:) Price: $0 (the Report). The Report alleges, among other things, fraudulent billing schemes, off-label misuse of its devices, and reliance on kickbacks to drive sales. The Report also alleges that the Company may be under regulatory scrutiny by the U.S. Department of Justice, Internal Revenue Service, and state attorneys general for Medicare fraud linked to organ acquisition costs.

    On this news, the price of TransMedics stock fell by $3.74, or 5.16%, to close at $68.81 on January 10, 2025.

    WHY CONTACT KAPLAN FOX – Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

    This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

    If you have any questions about this investigation, please contact:

    Pamela A. Mayer

    KAPLAN FOX & KILSHEIMER LLP

    800 Third Avenue, 38th Floor

    New York, New York 10022

    (646) 315-9003

    pmayer@kaplanfox.com

    Laurence D. King

    KAPLAN FOX & KILSHEIMER LLP

    1999 Harrison Street, Suite 1560

    Oakland, California 94612

    (415) 772-4704

    lking@kaplanfox.com

    View the original release on www.newmediawire.com

    Copyright 2025 JCN Newswire . All rights reserved.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleMoney market account rates today, January 11, 2025 (best account provides 4.85% APY)
    Next Article FTSE shares: a bargain way to start building wealth in 2025?
    user
    • Website

    Related Posts

    Has Warren Buffett made his best move ever selling his Apple stock?

    June 7, 2025

    This FTSE 100 stock goes ex-dividend on 26 June — time to bag a 6.9% yield?

    June 7, 2025

    Is this the Tesla stock buying opportunity I’ve been waiting for?

    June 7, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d